Patent Assignment
Reel/Frame 055365/0914
Assignment of Assignor's Interest
Recorded: 2021-02-23
Pages: 9
Assignor
PHARMORPHIX
Executed: 2015-03-16
Assignee
EXELIXIS, INC.
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(2)
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 23, 2021
From: GALLAGHER, WILLIAM P.
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 055365/0289 →
Assignment of Assignor's Interest
Feb 23, 2021
From: LAMB, PETER
To: EXELIXIS, INC.
Reel/Frame 055365/0395 →
Assignment of Assignor's Interest
Feb 23, 2021
From: ST. CLAIR BROWN, ADRIAN
To: PHARMORPHIX
Reel/Frame 055365/0605 →
Assignment of Assignor's Interest
Feb 23, 2021
From: BRISTOL-MYERS SQUIBB COMPANY
To: EXELIXIS, INC.
Reel/Frame 055365/0818 →